Sutton Wealth Advisors Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$25,397
+5.4%
7120.0%0.01%0.0%
Q3 2022$24,101
+17.0%
7120.0%0.01%
+25.0%
Q2 2022$20,591
-27.5%
712
-19.0%
0.01%
-20.0%
Q1 2022$28,409
+13.4%
879
+2.3%
0.01%
+25.0%
Q4 2021$25,048
+33.4%
859
+22.0%
0.01%
+14.3%
Q3 2021$18,776
-13.4%
7040.0%0.01%
-12.5%
Q2 2021$21,676
+17.6%
7040.0%0.01%
+14.3%
Q1 2021$18,431
+4.1%
7040.0%0.01%
-12.5%
Q4 2020$17,713
+20.7%
7040.0%0.01%
+14.3%
Q3 2020$14,671
-12.3%
7040.0%0.01%
-22.2%
Q2 2020$16,720
+32.0%
7040.0%0.01%
+12.5%
Q1 2020$12,665
-27.7%
704
-4.7%
0.01%
-11.1%
Q4 2019$17,529
-9.4%
739
+5.0%
0.01%
-18.2%
Q3 2019$19,346
-17.0%
7040.0%0.01%
-15.4%
Q2 2019$23,295
-5.6%
7040.0%0.01%
-7.1%
Q1 2019$24,668
-5.5%
704
-10.4%
0.01%
-17.6%
Q4 2018$26,111
-26.3%
786
+11.6%
0.02%
-26.1%
Q3 2018$35,446
-15.9%
7040.0%0.02%
-20.7%
Q2 2018$42,134
+30.7%
7040.0%0.03%
+26.1%
Q1 2018$32,243
+14.9%
7040.0%0.02%
+9.5%
Q4 2017$28,054
-0.4%
7040.0%0.02%0.0%
Q3 2017$28,160
-7.2%
7040.0%0.02%
-12.5%
Q2 2017$30,342
+37.7%
7040.0%0.02%
+33.3%
Q1 2017$22,035
+24.0%
7040.0%0.02%
+12.5%
Q4 2016$17,776
+2.1%
7040.0%0.02%0.0%
Q3 2016$17,410
+21.4%
7040.0%0.02%
+14.3%
Q2 2016$14,340
+33.6%
7040.0%0.01%
+40.0%
Q1 2016$10,7367040.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders